Viewing Study NCT03533127


Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT03533127
Status: UNKNOWN
Last Update Posted: 2018-07-10
First Post: 2018-05-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer
Sponsor: Luye Pharma Group Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module